Correlation Between Akero Therapeutics and Krystal Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Akero Therapeutics and Krystal Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akero Therapeutics and Krystal Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akero Therapeutics and Krystal Biotech, you can compare the effects of market volatilities on Akero Therapeutics and Krystal Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akero Therapeutics with a short position of Krystal Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akero Therapeutics and Krystal Biotech.

Diversification Opportunities for Akero Therapeutics and Krystal Biotech

-0.3
  Correlation Coefficient

Very good diversification

The 3 months correlation between Akero and Krystal is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Akero Therapeutics and Krystal Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Krystal Biotech and Akero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akero Therapeutics are associated (or correlated) with Krystal Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Krystal Biotech has no effect on the direction of Akero Therapeutics i.e., Akero Therapeutics and Krystal Biotech go up and down completely randomly.

Pair Corralation between Akero Therapeutics and Krystal Biotech

Given the investment horizon of 90 days Akero Therapeutics is expected to generate 1.27 times less return on investment than Krystal Biotech. In addition to that, Akero Therapeutics is 1.28 times more volatile than Krystal Biotech. It trades about 0.1 of its total potential returns per unit of risk. Krystal Biotech is currently generating about 0.16 per unit of volatility. If you would invest  17,689  in Krystal Biotech on August 28, 2024 and sell it today you would earn a total of  1,767  from holding Krystal Biotech or generate 9.99% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Akero Therapeutics  vs.  Krystal Biotech

 Performance 
       Timeline  
Akero Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Akero Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Akero Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.
Krystal Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Krystal Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Krystal Biotech is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Akero Therapeutics and Krystal Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Akero Therapeutics and Krystal Biotech

The main advantage of trading using opposite Akero Therapeutics and Krystal Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akero Therapeutics position performs unexpectedly, Krystal Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Krystal Biotech will offset losses from the drop in Krystal Biotech's long position.
The idea behind Akero Therapeutics and Krystal Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency